Kallabis, DE
Gabriel Kallabis, Spirkelbach DE
Patent application number | Description | Published |
---|---|---|
20080216332 | Spirit Level - The invention relates to a spirit level comprising a spirit level body ( | 09-11-2008 |
20090113731 | ARRANGEMENT FOR DEPICTING A LINEAR MARKING - An arrangement for depicting a linear optical marking on a surface, including a radiation source emitting light, such as laser radiation, as well as a first lens arranged in the beam path having a first and a second surface penetrated by the radiation, of which one surface features a parabolic or elliptical trace at least partially in cross section, formed of curved sections of different radii, the trace extending symmetrically with respect to a plane of symmetry of the lens, along which runs the beam directed in parallel, preferably by means of a second lens. In order to achieve a uniform power distribution along the line, it is proposed that the first surface formed of sections with different radii faces the radiation. | 05-07-2009 |
20090139102 | SPIRIT LEVEL - The invention concerns a spirit level ( | 06-04-2009 |
20100050447 | LASER DEVICE - A laser device, including a cradle with a laser unit exiting from this, the cradle being connected to a base element, relative to which the cradle can be adjusted in terms of inclination by at least one actuating drive. In order to achieve a secure mounting of the cradle for the laser unit with simple structural means, while at the same time eliminating any play between the mutually tilting parts, it is proposed that the cradle be connected to the base element, first, by a solid joint, and secondly by two adjusting drives, wherein the adjusting drives are arranged with respect to the solid joint so that the lines of connection between lengthwise axis of the solid joint and the adjusting drives subtend a right angle. | 03-04-2010 |
20110265340 | SPIRIT LEVEL - A spirit level including a profiled body with a bottom wall which makes available a first outer measurement surface, a head wall facing this bottom wall, with a second outer surface, which runs at least in sections parallel to the measurement surface, and side walls which connect the bottom wall to the head wall, and which present a first or second outer lateral face. The profiled body presents at least one bubble vial body, whose bubble vial can be detected optically via a notch which passes through the head wall. For the spirit level body to present secure gripping and handling, and a stable base, it is proposed that the profiled body with respect to its vertical axis which runs perpendicularly to the measurement surface, present an asymmetric design on the lateral face over the length of the profiled body, where a first lateral face viewed in the longitudinal direction of the profiled body, presents a channel-shaped course, and a facing second lateral face includes a first section which runs on the head side and has a convex course, and a subsequent second section, whose separation from the vertical axis of the profiled body increases starting from the first section in the direction of the measurement surface. | 11-03-2011 |
20110266425 | Device for capturing a laser beam - The invention relates to a device for capturing a laser beam, comprising a receiver unit having a housing with a front surface, along one side of which a measurement region capturing the laser beam that comprises a sensor associated therewith runs, and a mounting ( | 11-03-2011 |
Harald Kallabis, Koln DE
Patent application number | Description | Published |
---|---|---|
20090138204 | Single nucleotide polymorphisms sensitively predicting adverse drug reactions (ADR) and drug efficacy - Provided are diagnostic methods and kits including oligo and/or polynucleotides or derivatives, including as well antibodies determining whether a human subject is at risk of getting adverse drug reaction after statin therapy or whether the human subject is a high or low responder or a good a or bad metabolizer of statins. The diagnostic methods and kits including antibodies determining whether a human subject is at risk for a cardiovascular disease. Also provided are polymorphic sequences and other genes and isolated polynucleotides encoding a phenotype associated (PA) gene polypeptide useful in methods to identify therapeutic agents and useful for preparation of a medicament to treat cardiovascular disease or influence drug response. | 05-28-2009 |
20110003804 | Oxazolidinones For the Treatment and/or Prophylaxis of Heart Failure - The present invention relates to the use of selective inhibitors of coagulation factor Xa, in particular of oxazolidinones of the formula (I), for the treatment and/or prophylaxis of heart failure and/or disorders related to heart failure as well as their use for the preparation of pharmaceutical drugs for the treatment and/or prophylaxis of heart failure and/or disorders related to heart failure. | 01-06-2011 |
Harald Kallabis, Leverkusen DE
Patent application number | Description | Published |
---|---|---|
20090093689 | METHOD FOR IDENTIFYING PREDICTIVE BIOMARKERS FROM PATIENT DATA - The invention relates to a method for developing a biomarker for the prognosis of the result of a therapeutical treatment based on data obtained in clinical studies, data remaining unchanged by therapy being subdivided into diagnostic and genomic parameters and the marker being defined by a combination of parameters. The method according to the invention is characterized by specifying the maximum number of parameters for defining the marker and thus the maximum complexity of the system from the beginning and by carrying out the search for defining parameters by sequential combination of clinical parameters (=z parameters) and/or genomic parameters (=x parameters). | 04-09-2009 |
20090208945 | Method for the Prediction of Adverse Drug Responses to Stains - The invention provides diagnostic methods and kits including oligo and/or polynucleotides or derivatives, including as well antibodies determining whether a human subject is at risk of getting adverse drug reaction after statin therapy. Still further the invention provides polymorphic sequences and other genes. The present invention further relates to isolated polynucleotides encoding a SADR gene polypeptide useful in methods to identify therapeutic agents and useful for preparation of a medicament to treat statin induced adverse drug reactions (SADR), the polynucleotide is selected from the group comprising: SEQ ID 1-35 with allelic variation as indicated in the sequences section contained in a functional surrounding like full length cDNA for SADR gene polypeptide and with or without the SADR gene promoter sequence. | 08-20-2009 |
20090208967 | Genetic Polymorphisms As Predictive Diagnostics For Adverse Drug Reactions (ADR) And Drug Efficacy - The invention provides diagnostic methods and kits including oligo and/or polynucleotides or derivatives, including as well antibodies determining whether a human subject is at risk of getting adverse drug reaction after statin therapy or whether the human subject is a high or low responder or a good a or bad metabolizer of statins. The invention provides further diagnostic methods and kits including antibodies determining whether a human subject is at risk for a cardiovascular disease. Still further the invention provides polymorphic sequences and other genes. | 08-20-2009 |
20100190169 | SINGLE NUCLEOTIDE POLYMORPHISMS PREDICTING CARDIOVASCULAR DISEASE - The present invention relates to an isolated polynucleotide encoding a Na | 07-29-2010 |